These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 23280993

  • 1. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L, Fan W, Cai P, Fan M, Zhu X, Dai Y, Sun C, Cheng Y, Zheng P, Zhao BQ.
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [Abstract] [Full Text] [Related]

  • 2. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ, Cao C, Fredriksson L, Nilsson I, Stefanitsch C, Stevenson TK, Zhao J, Ragsdale M, Sun YY, Yepes M, Kuan CY, Eriksson U, Strickland DK, Lawrence DA, Zhang L.
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Oct; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 4. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T, Irie K, Hayakawa K, Sano K, Nakamura Y, Tanaka M, Yamashita Y, Satho T, Fujioka M, Muroi C, Matsuo K, Ishikura H, Futagami K, Mishima K.
    Brain Res; 2015 Oct 22; 1624():330-335. PubMed ID: 26254727
    [Abstract] [Full Text] [Related]

  • 5. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J.
    Transl Stroke Res; 2016 Jun 22; 7(3):209-19. PubMed ID: 27018013
    [Abstract] [Full Text] [Related]

  • 6. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y, Nagai N, Yamakawa K, Muranaka Y, Hokamura K, Umemura K.
    J Cereb Blood Flow Metab; 2015 Dec 22; 35(12):2021-31. PubMed ID: 26219596
    [Abstract] [Full Text] [Related]

  • 7. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC, Bengualid DJ, Da Silva RF, Kargiotis O, Schaller K, Gasche Y.
    Eur J Neurosci; 2011 Oct 22; 34(7):1085-92. PubMed ID: 21895804
    [Abstract] [Full Text] [Related]

  • 8. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P.
    Stroke; 2013 Mar 22; 44(3):699-707. PubMed ID: 23422087
    [Abstract] [Full Text] [Related]

  • 9. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 10. ADAMTS13 exerts a thrombolytic effect in microcirculation.
    Crescente M, Thomas GM, Demers M, Voorhees JR, Wong SL, Ho-Tin-Noé B, Wagner DD.
    Thromb Haemost; 2012 Sep 15; 108(3):527-32. PubMed ID: 22782575
    [Abstract] [Full Text] [Related]

  • 11. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S, Lee JH, Wali B, Stein DG, Sayeed I.
    J Cereb Blood Flow Metab; 2014 Jan 15; 34(1):72-80. PubMed ID: 24045404
    [Abstract] [Full Text] [Related]

  • 12. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I.
    Stroke; 2017 Jun 15; 48(6):1695-1699. PubMed ID: 28428349
    [Abstract] [Full Text] [Related]

  • 13. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul 15; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 14. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.
    Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD.
    Blood; 2009 Oct 08; 114(15):3329-34. PubMed ID: 19687510
    [Abstract] [Full Text] [Related]

  • 15. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
    Niego B, Medcalf RL.
    J Cereb Blood Flow Metab; 2014 Aug 08; 34(8):1283-96. PubMed ID: 24896566
    [Abstract] [Full Text] [Related]

  • 16. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M, Kawasaki K, Suzuki Y, Ishizuka F, Mishiro K, Egashira Y, Ikegaki I, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H.
    Neuroscience; 2012 Sep 18; 220():302-12. PubMed ID: 22710066
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
    Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J.
    Neurobiol Dis; 2017 Dec 18; 108():173-182. PubMed ID: 28830843
    [Abstract] [Full Text] [Related]

  • 18. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
    Zhang L, Zhang ZG, Liu XS, Hozeska-Solgot A, Chopp M.
    Arterioscler Thromb Vasc Biol; 2007 Nov 18; 27(11):2470-5. PubMed ID: 17717296
    [Abstract] [Full Text] [Related]

  • 19. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 18; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 20. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
    Yao SQ, Ye Y, Li Q, Wang XY, Yan L, Huo XM, Pan CS, Fu Y, Liu J, Han JY.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):117024. PubMed ID: 37572928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.